Please join us for the kick-off of the new "Let's Talk About It" series of discussion programs. Presented quarterly at our location inside the United Way Building at 742 Delaware Ave in Buffalo, we will serve light refreshments at 6:00 PM and our speaker will begin at approximately 6:30 PM. There will also be time to socialize until we conclude at 8:00 PM. For those not able to attend in person, the program will be available on Zoom starting at 6:30. Please register for the Zoom Webinar here.

Our November 19th program features a very interesting discussion about Clinical Genomics and identifying individuals who are at high risk for breast cancer through genetic testing and other means. Here is a brief biography from our guest expert, Dr. Kenan Onel of Roswell Park Comprehensive Cancer Center.

I am a physician/scientist with more than 20 years’ experience in Oncology, Genetics and Genomics. As a physician, I am Board-certified in Pediatric Hematology/Oncology and have spent my career as a clinical cancer geneticist caring for children, adults, and families at high risk for cancer due to genetic predispositions or family history. As a scientist, I am known internationally for my work on the genetic contribution to cancer risk and response to therapy, and am recognized as a leader in functional genomics, an emerging field integrating genetic and laboratory investigations that is yielding profound new insights into human health and disease. I have a long history of NIH and foundation funding, and has published almost 100 articles, reviews and book chapters.

I came to Roswell Park as the Chief of Clinical Genomics to build a novel and innovative medical specialty home to diagnose and provide ongoing precision care for patients and families at high risk of cancer because of their genetics or family history. As Director of the Center for Precision Oncology and Cancer Prevention in the Department of Cancer Prevention and Control, I am establishing a translational research program utilizing cutting-edge genomic technologies to investigate the actions and interactions of genetic and non-genetic factors in cancer etiology, cancer evolution, and the emergence of therapy-resistance in tumors. The Center will also provide a platform for multi-disciplinary collaborative research in translational cancer genomics, bridging the bench and the bedside.

Lets Talk About It: Clinical Genomics

Clinical Genomics & Identifying High Risk Breast Cancer with Dr. Kenan Onel, Roswell Park